GT Biopharma Inc. (GTBP)
NASDAQ: GTBP
· Real-Time Price · USD
0.71
0.07 (11.18%)
At close: Oct 06, 2025, 11:51 AM
11.18% (1D)
| Bid | 0.63 |
| Market Cap | 2.52M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.39M |
| EPS (ttm) | -3.98 |
| PE Ratio (ttm) | -0.18 |
| Forward PE | -1.03 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.64 |
| Volume | 623,526 |
| Avg. Volume (20D) | 295,115 |
| Open | 0.70 |
| Previous Close | 0.64 |
| Day's Range | 0.64 - 0.71 |
| 52-Week Range | 0.55 - 4.10 |
| Beta | 1.32 |
| Ex-Dividend Date | n/a |
About GTBP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GTBP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GTBP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-7.59%
GT Biopharma shares are trading lower. The company...
Unlock content with
Pro Subscription
7 months ago
+21.18%
GT Biopharma shares are trading higher after the company announced a request for the withdrawal of form S-1 registration with the SEC.
